Tuberculosis Epidemiologic Studies Consortium III

The Centers for Disease Control and Prevention seeks to establish the Tuberculosis Epidemiologic Studies Consortium III through solicitation number 75D301-21-R-71814 to conduct epidemiologic research on decreasing the prevalence of untreated latent tuberculosis infection among non-U.S.-born populations. Offerors must propose protocols for identifying high-risk subpopulations, collecting electronic health record data from primary care settings serving at least 10,000 patients annually, designing and implementing clinical interventions to improve tuberculosis screening and treatment, and evaluating performance across the latent tuberculosis infection care cascade over multiple years. Proposals will be evaluated based on technical approach, past performance, and price/cost, and are due by July 9, 2021.

There is no set-aside designation. The NAICS code is 541715 for research and development in the social sciences and humanities, and PSC code is R425 for epidemiological and other health services. The base period of performance is from September 29, 2021 through March 28, 2023 with three optional one-year periods through March 28, 2026. Reimbursement will be on a cost-reimbursement basis with no fee. Work will be conducted at locations across the United States serving populations at risk for latent tuberculosis infection. The government estimates obligating approximately $5 million annually to support epidemiologic research activities through TBESC III.